Zymeworks
Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics. Learn more
Launch date
Employees
Market cap
AUD1.4b
Enterprise valuation
AUD898m (Public information from Sep 2024)
Share price
$13.05 ZYME
Vancouver British Columbia (HQ)
Authorizing premium user...